Global Information
회사소개 | 문의 | 위시리스트

중동의 바이러스 검사 및 미생물 검사 시장 : 주요 미생물 검사(100 종류)의 판매액 및 판매량, 경쟁 전략, 의료기기, 기술, 시장 기회

2017 Middle East Virology and Bacteriology Testing Market: Sales and Volume Forecasts for 100 Microbiology Tests, Competitive Strategies, Instrumentation, Technologies, Opportunities

리서치사 Venture Planning Group
발행일 상품 코드 439426
페이지 정보 영문 985 Pages
가격
US $ 5,750 ₩ 6,940,000 DataPack
US $ 9,500 ₩ 11,466,000 PDF by E-mail (Local license)
US $ 14,700 ₩ 17,742,000 PDF by E-mail (Global license)


중동의 바이러스 검사 및 미생물 검사 시장 : 주요 미생물 검사(100 종류)의 판매액 및 판매량, 경쟁 전략, 의료기기, 기술, 시장 기회 2017 Middle East Virology and Bacteriology Testing Market: Sales and Volume Forecasts for 100 Microbiology Tests, Competitive Strategies, Instrumentation, Technologies, Opportunities
발행일 : 페이지 정보 : 영문 985 Pages

중동 국가(바레인, 이란, 이라크, 이스라엘, 요르단, 쿠웨이트, 레바논, 오만, 카타르, 사우디아라비아, UAE)의 바이러스 검사 및 미생물 검사 시장을 분석했으며, 검사 방법 개요 및 현재 기술 수준, 주요 검사약, 국가별·검사 항목별(총 100 종류)·검정 방법별 시장 규모 동향 전망, 주요 공급업체의 개요·제품 포트폴리오·사업 전략, 향후 시장 기회 등을 조사·추산하여 전해드립니다.

목차 : 도표

  • 바레인
    • 감염증 검사 건수 예측 : 검정 방법별
    • 감염증 진단약 시장 규모 예측 : 검정 방법별
  • 이란
  • 이라크
  • 이스라엘
  • 요르단
  • 쿠웨이트
  • 레바논
  • 오만
  • 카타르
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 에이즈(AIDS) 검사약을 개발·출시하고 있는 주요 기업
  • 아데노바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 바르토넬라 검사약을 개발·출시하고 있는 주요 기업
  • 캄필로박터 검사약을 개발·출시하고 있는 주요 기업
  • 칸디다 검사약을 개발·출시하고 있는 주요 기업
  • 카바페네마제 검사약을 개발·출시하고 있는 주요 기업
  • 클라미디아 검사약을 개발·출시하고 있는 주요 기업
  • 클로스트리듐 검사약을 개발·출시하고 있는 주요 기업
  • 코로나바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 크립토스포리듐 검사약을 개발·출시하고 있는 주요 기업
  • 거대세포바이러스(CMV) 검사약을 개발·출시하고 있는 주요 기업
  • 에코바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 엔테로바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 엡스타인 바 바이러스(EBV) 검사약을 개발·출시하고 있는 주요 기업
  • 지아르디아 검사약을 개발·출시하고 있는 주요 기업
  • 임질 검사약을 개발·출시하고 있는 주요 기업
  • 한타바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 헬리코박터 파일로리 검사약을 개발·출시하고 있는 주요 기업
  • 간염 검사약을 개발·출시하고 있는 주요 기업
  • 헤르페스 검사약을 개발·출시하고 있는 주요 기업
  • 인플루엔자 검사약을 개발·출시하고 있는 주요 기업
  • 레지오넬라균 검사약을 개발·출시하고 있는 주요 기업
  • 라임병 검사약을 개발·출시하고 있는 주요 기업
  • 림프육아종 검사약을 개발·출시하고 있는 주요 기업
  • 말라리아 검사약을 개발·출시하고 있는 주요 기업
  • 홍역 검사약을 개발·출시하고 있는 주요 기업
  • 수막염 검사약을 개발·출시하고 있는 주요 기업
  • 미포자충목 검사약을 개발·출시하고 있는 주요 기업
  • 단핵증 검사약을 개발·출시하고 있는 주요 기업
  • 볼거리 검사약을 개발·출시하고 있는 주요 기업
  • 마이코플라스마 검사약을 개발·출시하고 있는 주요 기업
  • 노로바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 유두종 바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 파보바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 폐렴 검사약을 개발·출시하고 있는 주요 기업
  • 호흡기세포융합바이러스(RSV) 검사약을 개발·출시하고 있는 주요 기업
  • 로타바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 풍진 검사약을 개발·출시하고 있는 주요 기업
  • 살모넬라균 검사약을 개발·출시하고 있는 주요 기업
  • 패혈증 검사약을 개발·출시하고 있는 주요 기업
  • 세균성 이질 검사약을 개발·출시하고 있는 주요 기업
  • 포도상구균 검사약을 개발·출시하고 있는 주요 기업
  • 연쇄구균 검사약을 개발·출시하고 있는 주요 기업
  • 매독 검사약을 개발·출시하고 있는 주요 기업
  • 톡소플라스마증 검사약을 개발·출시하고 있는 주요 기업
  • 트리코모나스 검사약을 개발·출시하고 있는 주요 기업
  • 결핵 검사약을 개발·출시하고 있는 주요 기업
  • 웨스트 나일 바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 예르시니아 검사약을 개발·출시하고 있는 주요 기업
KSA 17.03.02

This new report from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The report provides granular market segmentation analysis and forecasts for over 100 microbiology tests; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and strategies for suppliers.

Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world's major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs. Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Carbapenemase, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes, Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Norovirus, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Country Analyses

Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates

Market Segmentation Analysis

- Test and sales forecasts for 100 infectious disease diagnostic assays by country, individual test and market segment:

- Review of market dynamics, trends, structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.

Technology Review

- Assessment of emerging diagnostic technologies and their potential applications for infectious disease testing.

- Companies developing or marketing infectious disease diagnostic products by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Opportunities and Strategies for Suppliers

- Emerging opportunities for new instrumentation, reagent systems, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Contains 985 pages and 145 tables

Table of Contents

List of Tables

  • Bahrain
  • All Market Segments Infectious Disease Test Volume Forecast by Assay
  • Bahrain
  • All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
  • Iran
  • All Market Segments Infectious Disease Test Volume Forecast by Assay
  • Iran
  • All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
  • Iraq
  • All Market Segments Infectious Disease Test Volume Forecast by Assay
  • Iraq
  • All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
  • Israel
  • All Market Segments Infectious Disease Test Volume Forecast by Assay
  • Israel
  • All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
  • Jordan
  • All Market Segments Infectious Disease Test Volume Forecast by Assay
  • Jordan
  • All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
  • Kuwait
  • All Market Segments Infectious Disease Test Volume Forecast by Assay
  • Kuwait
  • All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
  • Lebanon
  • All Market Segments Infectious Disease Test Volume Forecast by Assay
  • Lebanon
  • All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
  • Oman
  • All Market Segments Infectious Disease Test Volume Forecast by Assay
  • Oman
  • All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
  • Qatar
  • All Market Segments Infectious Disease Test Volume Forecast by Assay
  • Qatar
  • All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
  • Saudi Arabia
  • All Market Segments Infectious Disease Test Volume Forecast by Assay
  • Saudi Arabia
  • All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
  • United Arab Emirates
  • All Market Segments Infectious Disease Test Volume Forecast by Assay
  • United Arab Emirates
  • All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Bartonella Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing Carbapenemase Tests
  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Clostridium Tests
  • Major Companies Developing or Marketing Coronavirus Tests
  • Major Companies Developing or Marketing Cryptosporidium Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Echovirus Tests
  • Major Companies Developing or Marketing Enterovirus Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Giardia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Hantavirus Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma Tests
  • Major Companies Developing or Marketing Malaria Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Microsporidium Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Norovirus Tests
  • Major Companies Developing or Marketing Papilloma Virus Tests
  • Major Companies Developing or Marketing Parvovirus Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Septicemia Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Staphylococci Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Toxoplasmosis Tests
  • Major Companies Developing or Marketing Trichomonas Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Major Companies Developing or Marketing West Nile Tests
  • Major Companies Developing or Marketing Yersinia Tests
Back to Top
전화 문의
F A Q